CHECKPOINT INHIBITORS - Novel Targets & Global Markets
A combination of PD‑1/PD‑L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review)
Anti-PD-1 Inhibitors – Melanoma Unit
Revisiting the PD-1 pathway
Impact Story: Determining the Clinical Benefit of Treatment Beyond Progression with Immune Checkpoint Inhibitors | FDA
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC) | Journal for ImmunoTherapy of Cancer
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer | Oncology
PD-1/PD-L1 Landscape Analysis - Cancer Research Institute (CRI)
Frontiers | Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice | Immunology
Recent advance of peptide-based molecules and nonpeptidic small-molecules modulating PD-1/PD-L1 protein-protein interaction or targeting PD-L1 protein degradation - ScienceDirect
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review | Cancer Cell International | Full Text
Immune Checkpoint Inhibitor Side Effects & Toxicity More Common Than Reported - CancerConnect
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake | Pharmacology
In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors
PDB-101: Molecule of the Month: PD-1 (Programmed Cell Death Protein 1)
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors | Cell and Developmental Biology
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure) - Annals of Oncology
PD-1 and PD-L1 Inhibitors Market Size, Trends, Opportunities & Forecast
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
PD-1 inhibitor| Investigational Compounds | InOncology
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | Acta Pharmacologica Sinica
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
How to approach immune checkpoint inhibitor therapy in prostate cancer
Mechanism of action of PD-1 and PD-L1 inhibitors. Tumor cells develop... | Download Scientific Diagram
